Companies: 10,795·Total market cap: $144.5T
CohBar, Inc.

CohBar, Inc.

CWBRNASDAQHealthcare
$0.41
+$0.00(+0.00%)
Market Cap$1191841
P/E Ratio
52W High$1.01
52W Low$0.0011
Overview

CohBar, Inc. (CWBR) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cwbr · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for CohBar, Inc. (CWBR) measures how much investors pay for each dollar of the company's trailing earnings. CWBR's current PE ratio of N/A is calculated by dividing its stock price of $0.41 by its TTM earnings per share of -$4.13.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2025 est. EPS $-10.50
Based on 1 analyst
EPS (TTM)
-$4.13
TTM · diluted EPS
PEG Ratio
-0.03
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CohBar, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2011 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
CohBar, Inc.
CohBar, Inc.You
CWBR
$1MN/A-$4.13
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc.
BLCM
$1MN/A-$0.81
Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd.
CYTO
$1MN/A$0.00
HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.
HTGMQ
$0MN/A-$24.28
Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc.
IMPL
$1MN/A-$5.52
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc.
NBSE
$1MN/A-$21.08
9 Meters Biopharma, Inc.
9 Meters Biopharma, Inc.
NMTRQ
$0MN/A

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 12 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-4.13
2021-12-31
FY2021
$-6.94
2020-12-31
FY2020
$-8.99
2019-12-31
FY2019
$-9.56
2018-12-31
FY2018
$-11.42
2017-12-31
FY2017
$-7.87
2016-12-31
FY2016
$-5.50
2015-12-31
FY2015
$-3.63
2014-12-31
FY2014
$-3.08
2013-12-31
FY2013
$-2.03

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for CohBar, Inc. (CWBR) measures how much investors pay for each dollar of the company's trailing earnings. CWBR's current PE ratio of N/A is calculated by dividing its stock price of $0.41 by its TTM earnings per share of -$4.13.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.41 ÷ -$4.13 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CWBR pe ratio · 6 questions

CWBR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.41 and TTM EPS of -$4.13. Data sourced from Financial Modeling Prep via CWBR's SEC 10-K and 10-Q filings.

CWBR PE ratioWhat is CWBR PE ratioCurrent PE ratio of CWBRCWBR PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CohBar, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09